Electroencephalography (EEG) microstate analysis has emerged as a key methodology for elucidating the brain's dynamic repertoire, providing a pivotal neurophysiological framework for the identification of cognitive impairment.
Objective
This study was aimed to analyze the EEG microstates in Alzheimer's disease (AD) based on a publicly accessible EEG dataset and additionally using support vector machine models to separate the healthy controls and AD patients.
Methods
This scalp EEG dataset from an open-source included 36 AD patients and 29 healthy controls. All EEG data underwent standardized preprocessing incorporating a 0.5–35 Hz band-pass filter and automated artifact rejection. The EEG data were subsequently partitioned into 20-s segments for microstate analysis, generating temporally aligned sequences characterized by canonical four-class spatial configurations.
Results
A total of 24 features were extracted from microstate sequences, including coverage, mean duration, occurrence, and transition probabilities between each two microstates. The statistical testing results indicated that there were significant differences in 21 features between AD patients and healthy controls. Based on the features of statistical significance, we implemented support vector machine models to distinguish the AD patients from the healthy controls, achieving an averaged classification accuracy of 75.8% in a 5-fold cross-subject validation via 10 times repeated random trials.
Conclusions
The EEG microstate analysis methods was a non-invasive, convenient, and efficient technical pathway and could be adopted for identifying AD.
BatemanRJLiYMcDadeEM, et al.Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol2025; 24: 316–330.
2.
Arroyo-PachecoNSarmiento-BlancoSVergara-CadavidG, et al.Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: a systematic review and meta-analysis. Ageing Res Rev2025; 104: 102620.
3.
LianHLiYLiY. Altered EEG microstate dynamics in mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol2021; 132: 2861–2869.
4.
VicchiettiMLRamosFMBettingLE, et al.Computational methods of EEG signals analysis for Alzheimer's disease classification. Sci Rep2023; 13: 8184.
5.
AtriA. The Alzheimer's disease clinical spectrum: diagnosis and management. Med Clin North Am2019; 103: 263–293.
6.
YangQLiXDingX, et al.Deep learning-based speech analysis for Alzheimer's disease detection: a literature review. Alzheimers Res Ther2022; 14: 186.
7.
ChaJHwangJMJoHJ, et al.Assessment of functional characteristics of amnestic mild cognitive impairment and Alzheimer's disease using various methods of resting-state FMRI analysis. Biomed Res Int2015; 2015: 907464.
8.
TeipelSJMetzgerCDBrosseronF, et al.Multicenter resting state functional connectivity in prodromal and dementia stages of Alzheimer's disease. J Alzheimers Dis2018; 64: 801–813.
9.
O'ConnellAQuinlanLKwakowskyA. β-amyloid's neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review. Pharmacol Res2024; 209: 107436.
10.
Calvo-Flores GuzmánBElizabeth ChaffeyTHansika PalpagamaT, et al.The interplay between beta-amyloid 1-42 (Aβ(1-42))-induced hippocampal inflammatory response, p-tau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits. Front Mol Neurosci2020; 13: 522073.
11.
JanelidzeSAshtonNJOrduña DoladoA, et al.A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease. Alzheimers Dement2025; 21: e70208.
12.
CodyKADuLStuderRL, et al.Accuracy of plasma biomarkers to detect Alzheimer's disease proteinopathy prior to dementia. Alzheimers Dement2025; 21: e14570.
13.
MichelCMKoenigT. EEG Microstates as a tool for studying the temporal dynamics of whole-brain neuronal networks: a review. Neuroimage2018; 180: 577–593.
14.
VKRRajagopalanSSBhardwajS, et al.Machine learning detects EEG microstate alterations in patients living with temporal lobe epilepsy. Seizure2018; 61: 8–13.
15.
KikuchiMKoenigTMunesueT, et al.EEG Microstate analysis in drug-naive patients with panic disorder. PLoS One2011; 6: e22912.
16.
KimKDucNTChoiM, et al.EEG Microstate features for schizophrenia classification. PLoS One2021; 16: e0251842.
17.
ChenJZhaoZShuQ, et al.Feature extraction based on microstate sequences for EEG-based emotion recognition. Front Psychol2022; 13: 1065196.
18.
da CruzJRFavrodORoinishviliM, et al.EEG Microstates are a candidate endophenotype for schizophrenia. Nat Commun2020; 11: 3089.
19.
LiuHTangHWeiW, et al.Altered peri-seizure EEG microstate dynamics in patients with absence epilepsy. Seizure2021; 88: 15–21.
20.
BochetASperdinHFRihsTA, et al.Early alterations of large-scale brain networks temporal dynamics in young children with autism. Commun Biol2021; 4: 968.
21.
TaitLTamagniniFStothartG, et al.EEG Microstate complexity for aiding early diagnosis of Alzheimer's disease. Sci Rep2020; 10: 17627.
22.
KavčičABorkoDKKodričJ, et al.EEG Alpha band functional brain network correlates of cognitive performance in children after perinatal stroke. Neuroimage2024; 297: 120743.
23.
ZhaoKDingYHanY, et al.Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer's disease: diagnosis, longitudinal progress and biological basis. Sci Bull (Beijing)2020; 65: 1103–1113.
24.
YuWYSunTHHsuKC, et al.Comparative analysis of machine learning algorithms for Alzheimer's disease classification using EEG signals and genetic information. Comput Biol Med2024; 176: 108621.
25.
MiltiadousATzimourta KDAfrantouT, et al.A dataset of scalp EEG recordings of Alzheimer's disease, frontotemporal dementia and healthy subjects from routine EEG. Data (Basel)2023; 8: 95.
26.
McKhannGDrachmanDFolsteinM, et al.Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology1984; 34: 939–944.
27.
DelormeASejnowskiTMakeigS. Enhanced detection of artifacts in EEG data using higher-order statistics and independent component analysis. Neuroimage2007; 34: 1443–1449.
28.
KhannaAPascual-LeoneAMichelCM, et al.Microstates in resting-state EEG: current status and future directions. Neurosci Biobehav Rev2015; 49: 105–113.
29.
GiulianoLMostileGFatuzzoD, et al.Abnormal visual sensitivity in eyelid myoclonia with absences: evidence from electrocortical connectivity and non-linear quantitative analysis of EEG signal. Seizure2019; 69: 118–124.
30.
CustoAVan De VilleDWellsWM, et al.Electroencephalographic resting-state networks: source localization of microstates. Brain Connect2017; 7: 671–682.
31.
HoenigMCBischofGNSeemillerJ, et al.Networks of tau distribution in Alzheimer's disease. Brain2018; 141: 568–581.
32.
Guzmán-VélezEDiezISchoemakerD, et al.Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease. Proc Natl Acad Sci U S A2022; 119: e2113641119.
33.
OssenkoppeleRSchonhautDRSchöllM, et al.Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain2016; 139: 1551–1567.
34.
HanssonOGrotheMJStrandbergTO, et al.Tau pathology distribution in Alzheimer's disease corresponds differentially to cognition-relevant functional brain networks. Front Neurosci2017; 11: 167.
35.
SmailovicUKoenigTLaukkaEJ, et al.EEG Time signature in Alzheimeŕs disease: functional brain networks falling apart. Neuroimage Clin2019; 24: 102046.
36.
L'EsperanceOJMcGheeJDavidsonG, et al.Functional connectivity favors aberrant visual network c-fos expression accompanied by cortical synapse loss in a mouse model of Alzheimer's disease. J Alzheimers Dis2024; 101: 111–131.
37.
RiegerKDiaz HernandezLBaenningerA, et al.15 Years of microstate research in schizophrenia - where are we? A meta-analysis. Front Psychiatry2016; 7: 22.
38.
YanYGaoMGengZ, et al.Abnormal EEG microstates in Alzheimer's disease: predictors of β-amyloid deposition degree and disease classification. Geroscience2024; 46: 4779–4792.
39.
MusaeusCSEngedalKHøghP, et al.Changes in the left temporal microstate are a sign of cognitive decline in patients with Alzheimer's disease. Brain Behav2020; 10: e01630.
40.
MaYBlandJFujinamiT. Classification of Alzheimer's disease and frontotemporal dementia using electroencephalography to quantify communication between electrode pairs. Diagnostics (Basel)2024; 14: 2189.
41.
StefanouKTzimourtaKDBellosC, et al.A novel CNN-based framework for Alzheimer's disease detection using EEG spectrogram representations. J Pers Med2025; 15: 27.
